Rachel L ODonnell
Overview
Explore the profile of Rachel L ODonnell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCormick A, Donoghue P, Dixon M, OSullivan R, ODonnell R, Murray J, et al.
Clin Cancer Res
. 2024 Aug;
30(16):3640.
PMID: 39143885
No abstract available.
2.
Robinson H, Karpe M, Edidi I, Fisher A, Drew Y, Ralte A, et al.
Int J Gynecol Pathol
. 2020 Jan;
40(2):190-195.
PMID: 31985580
Vulval cancer is rare. With Bartholin gland carcinomas representing <5% of all vulval carcinomas they present both diagnostic and management challenges. There are a small number of cases in the...
3.
Gentles L, Goranov B, Matheson E, Herriott A, Kaufmann A, Hall S, et al.
Cancers (Basel)
. 2019 Mar;
11(3).
PMID: 30871186
Dysfunctional homologous recombination DNA repair (HRR), frequently due to BRCA mutations, is a determinant of sensitivity to platinum chemotherapy and poly(ADP-ribose) polymerase inhibitors (PARPi). In cultures of ovarian cancer cells,...
4.
ODonnell R, Angelopoulos G, Beirne J, Biliatis I, Bolton H, Bradbury M, et al.
BMJ Open
. 2019 Jan;
9(1):e024853.
PMID: 30679297
Objectives: Surgical site infection (SSI) complicates 5% of all surgical procedures in the UK and is a major cause of postoperative morbidity and a substantial drain on healthcare resources. Little...
5.
McCormick A, Donoghue P, Dixon M, OSullivan R, ODonnell R, Murray J, et al.
Clin Cancer Res
. 2016 Oct;
23(8):2050-2060.
PMID: 27702817
DNA damage defects are common in ovarian cancer and can be used to stratify treatment. Although most work has focused on homologous recombination (HR), DNA double-strand breaks are repaired primarily...
6.
ODonnell R, Kaufmann A, Woodhouse L, McCormick A, Cross P, Edmondson R, et al.
Int J Gynecol Cancer
. 2016 Jun;
26(6):1004-11.
PMID: 27327149
Introduction: Epithelial ovarian cancer is recognized to be heterogeneous but is currently treated with a single treatment strategy. Successful patient stratification of emerging chemotherapy agents is dependent upon the availability...
7.
Dent B, Ogle L, ODonnell R, Hayes N, Malik U, Curtin N, et al.
Int J Cancer
. 2015 Jul;
138(1):206-16.
PMID: 26178530
Interest has increased in the potential role of circulating tumour cells in cancer management. Most cell-based studies have been designed to determine the number of circulating tumour cells in a...